Daniel V Ebner

14PUBLICATIONS
73CO-AUTHORS
Water treatment processesMolecular targetsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 14, 2023
Selective ROCK Inhibitor Enhances Blood Flow Recovery after Hindlimb Ischemia.

Hend Salah Fayed, Mouayad Zuheir Bakleh, Jasni Viralippurath Ashraf

|Aug 17, 2023
C16orf72/HAPSTR1/TAPR1 functions with BRCA1/Senataxin to modulate replication-associated R-loops and confer resistance to PARP disruption.

Abhishek Bharadwaj Sharma, Muhammad Khairul Ramlee, Joel Kosmin

|Jan 23, 2023
Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models.

Gonzalo Rodriguez-Berriguete, Marco Ranzani, Remko Prevo

|Nov 13, 2021
CHK1 inhibition exacerbates replication stress induced by IGF blockade.

Xiaoning Wu, Elena Seraia, Stephanie B Hatch

|Jul 29, 2021
A phenotypic high-content, high-throughput screen identifies inhibitors of NLRP3 inflammasome activation.

Sohaib Nizami, Val Millar, Kanisa Arunasalam

Pageof 3